QUEST LABORATORIES
|
QUEST LABORATORIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 9.08 | 8.37 | 8.46 | 46.77 | 38.05 |
| CEPS(Rs) | 9.58 | 8.69 | 8.93 | 5.19 | 4.23 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 59.08 | 50.01 | 24.01 | 139.97 | 92.64 |
| Tax Rate(%) | 17.20 | 27.18 | 30.13 | 27.74 | 28.82 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 16.32 | 15.40 | 18.85 | 12.73 | 10.87 |
| EBIT Margin(%) | 17.72 | 18.98 | 18.44 | 12.20 | 10.19 |
| Pre Tax Margin(%) | 16.06 | 18.11 | 17.50 | 11.33 | 9.69 |
| PAT Margin (%) | 13.30 | 13.19 | 12.23 | 8.18 | 6.90 |
| Cash Profit Margin (%) | 14.04 | 13.69 | 12.91 | 9.08 | 7.67 |
| Performance Ratios | |||||
| ROA(%) | 12.71 | 15.04 | 18.78 | 12.34 | 15.43 |
| ROE(%) | 16.64 | 24.79 | 46.13 | 40.21 | 51.69 |
| ROCE(%) | 18.27 | 27.04 | 57.51 | 46.54 | 55.00 |
| Asset Turnover(x) | 0.96 | 1.14 | 1.54 | 1.51 | 2.24 |
| Sales/Fixed Asset(x) | 6.20 | 6.89 | 6.10 | 5.33 | 6.54 |
| Working Capital/Sales(x) | 1.42 | 1.49 | 4.11 | 13.31 | 15.27 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.16 | 0.15 | 0.16 | 0.19 | 0.15 |
| Receivable days | 108.12 | 95.62 | 98.10 | 124.35 | 95.77 |
| Inventory Days | 97.90 | 65.81 | 60.30 | 36.25 | 5.88 |
| Payable days | 23.97 | 60.76 | 157.99 | 181.85 | 102.60 |
| Valuation Parameters | |||||
| PER(x) | 11.50 | 12.24 | - | - | - |
| PCE(x) | 10.90 | 11.79 | - | - | - |
| Price/Book(x) | 1.77 | 2.05 | - | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.60 | 1.90 | 0.20 | 0.08 | 0.04 |
| EV/Core EBITDA(x) | 8.67 | 9.78 | 1.07 | 0.63 | 0.40 |
| EV/EBIT(x) | 9.03 | 10.03 | 1.11 | 0.67 | 0.43 |
| EV/CE(x) | 1.71 | 1.76 | 0.50 | 0.26 | 0.20 |
| M Cap / Sales | 1.53 | 1.61 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 7.56 | 25.92 | 33.94 | 3.63 | 95.91 |
| Core EBITDA Growth(%) | 1.88 | 28.27 | 95.70 | 23.70 | 337.71 |
| EBIT Growth(%) | 0.40 | 29.63 | 102.46 | 24.03 | 452.92 |
| PAT Growth(%) | 8.45 | 35.85 | 100.08 | 22.90 | 526.72 |
| EPS Growth(%) | 8.45 | -1.04 | -81.92 | 22.90 | 526.72 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.08 | 0.37 | 0.18 | 0.27 | 0.31 |
| Current Ratio(x) | 6.83 | 2.88 | 1.67 | 1.16 | 1.17 |
| Quick Ratio(x) | 3.98 | 2.30 | 1.13 | 0.78 | 1.12 |
| Interest Cover(x) | 10.69 | 21.80 | 19.54 | 13.97 | 20.45 |
| Total Debt/Mcap(x) | 0.05 | 0.18 | - | - | - |
Compare Financial Ratios of peers of QUEST LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| QUEST LABORATORIES | ₹139.1 Cr | -0.1% | -11.7% | -2.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
QUEST LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| QUEST LABORATORIES | -0.1% |
-11.7% |
-2.1% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses
